We hypothesized that EpCAM would be a reasonable imaging target to accurately identify LNs with metastatic lung cancer cells and differentiate them from LNs without metastatic lung cancer cells. In this study we determine the imaging characteristics when targeting EpCAM in positive LNs compared to negative LNs in patients with lung cancer. The gene discussed is EPCAM; the disease is lung cancer.